Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Lancartama Sejati Tbk. (TAMA) Price & Performance

Indofarma Tbk.Trade
Lancartama Sejati Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Lancartama Sejati Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Lancartama Sejati Tbk. trades at Rp194 (market cap 235.2B, 610.9K 24h volume). The key difference: Indofarma Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

INAFTAMA
Market Cap
390.51B235.2B
Volume
610.9K
Lot
6.11K
Turnover
118.47M
Average Price
193.92
Value
118.47M
Indicative Equilibrium Price
194
Indicative Equilibrium Volume
868

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
TAMA
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Lancartama Sejati Tbk.

PT Lancartama Sejati Tbk (the Company) was established based on notary deed No. 12 dated June 01, 1990 of Sugiri Kadarisman, SH., notary in Jakarta.

Read more on TAMA